Abstract:The crystal structure of the title compound, (C10H9N2)2[Mn2(C10H8N2)3(H2O)8](C8H3O7S)2·C10H8N2·15H2O, consists of dinuclear MnII complex cations, sulfonatobenzenedicarboxylate trianions, 4-(4-pyridyl)pyridinium cations, uncoordinated 4,4′-bipyridine and uncoordinated water molecules. One 4,4′-bipyridine molecule bridges two Mn atoms, forming a centrosymmetric dinuclear complex; the mid-point of the C—C bond linking the pyridine rings of the bridging ligand is located on an inversion center. Each MnII atom is coordinated by four water and two 4,4′-bipyridine molecules in a distorted octahedral geometry. The MnII atom deviates by 0.591 (5) and 0.209 (2) Å from the mean planes of the coordinated pyridine rings. In the 4-(4-pyridyl)pyridinium cation, the two pyridine rings are twisted with respect to each other, making dihedral angle of 34.78 (17)°. The uncoordinated bipyridine molecule is also centrosymmetric. One of uncoordinated water molecules has site symmetry 2, and the other uncoordinated water molecule is located close to an inversion center and its one H atom is disordered equally over two sites. Extensive π–π stacking between pyridine rings is observed and an extensive hydrogen-bonding network of the types N—H...N, O—H...N and O—H...O is present.

1,4-Bis(carboxymethyl)piperazine-1,4-diium Bis(dihydrogen Phosphate) Dihydrate

4-Amino-2,3,5-trimethylpyridine Monohydrate

2-Amino-4-methylpyridinium 4-Aminobenzoate

3,6-Bis(4-hydroxybenzyl)piperazine-2,5-dione

N,N′-Bis(5,5-dimethyl-2-thioxo-1,3,2-dioxaphosphinan-2-yl)piperazine

Bis[4-(4-pyridyl)pyridinium] Μ-4,4′-bipyridine-bis[tetraaqua(4,4′-bipyridine)manganese(ii)] Bis(5-Sulfonatobenzene-1,3-dicarboxylate) 4,4′-Bipyridine Solvate Pentadecahydrate

N-(Dicyclopropylmethylamino)-4,5-dihydro-1,3-oxazolium Dihydrogenphosphate

Bis[4-(4-pyridyl)pyridinium] &#956;-4,4&#8242;-bipyridine-bis[tetraaqua(4,4&#8242;-bipyridine)manganese(II)] bis(5-sulfonatobenzene-1,3-dicarboxylate) 4,4&#8242;-bipyridine solvate pentadecahydrate

1,10-Phenanthrolinium 4-Chloro-2-hydroxybenzoate–1,10-phenanthroline–4-chloro-2-hydroxybenzoic Acid (1/1/1)

2,2′-Diamino-4,4′-bi-1,3-thiazol-3,3′-diium Bis(2,2′-Diamino-4,4′-bi-1,3-thiazol-3-ium) Tetrakis(2-Nitrobenzoate)

Tetra-aqua-(2,2'-bipyridine-κN,N')manganese(II) di-μ-aqua-bis-[aqua-(2,2'-bipyridine-κN,N')(5-sulfonatoisophthalato-κO)manganate(II)] tetra-hydrate.

Crystal structure of the piperazine-1,4-diium (DL-)hydrogen malate (1:2)

[(1H-Benzimidazol-2-ylmethyl)iminodimethylene]-diphosphonic Acid Dihydrate

4,4'-(Ethene-1,2-diyl)dipyridinium bis(2-hy-droxy-3-meth-oxy-benzoate)

Bis(piperazinium) Di-Μ-chloro-pentachlorotriiododibismuthate(iii) Tetrahydrate

4-Nitrophenylpiperazinium Chloride Monohydrate

2 : 1 Complex of 4-Methylphenol with Piperazine, Structure in the Solid and Solution State

1,1′-[(1,3-Dihydroxypropane-2,2-diyl)dimethylene] dipyridinium bis(hexafluorophosphate)

1,1'-[(1,3-Dihydroxypropane-2,2-diyl)dimethylene]dipyridinium bis-(hexa-fluoro-phosphate)

[H-2(C4h10n2)](2)(h2po4)(4): Hydrothermal Synthesis and Single Crystal Structure of an Inclusive Supramolecular Phosphoric Salt

Diaquabis(1,10-Phenanthroline-Kappa N-2,N ')zinc(ii) Pamoate Monohydrate